Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Rossari Biotech has informed that the Company will be participating in the investor and analyst meet/conference/events ‘B&K Securities' - Annual Investor Conference’ on 2nd June 2023. The discussion(s) and presentation at the meeting will be on the financial and other information available to the public or covered in the 'Earnings Presentation', which was submitted to the Stock Exchange(s) vide its letter dated April 30, 2023 and uploaded on its website.
The above information is a part of company’s filings submitted to BSE.